SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
-8.91%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$369M
AUM Growth
+$369M
(-5.7%)
Cap. Flow
+$31.6M
Cap. Flow
% of AUM
8.55%
Top 10 Holdings %
Top 10 Hldgs %
67.81%
Holding
26
New
2
Increased
16
Reduced
6
Closed
2
Top Buys
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$28.1M |
| 2 |
Johnson & Johnson
JNJ
|
$12.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
$10M |
| 4 |
Biogen
BIIB
|
$8.35M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$4.41M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$15.5M |
| 2 |
Stryker
SYK
|
$15.5M |
| 3 |
MDCO
Medicines Co
MDCO
|
$12.8M |
| 4 |
THOR
THORATEC CORPORATION
THOR
|
$10.2M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$1.03M |
Sector Composition
| 1 | Healthcare | 87.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$427B
| $39.2M | 10.62% | 420,100 +132,300 | +46% | +$12.4M |
|
2
Eli Lilly
LLY
$657B
| $30.6M | 8.29% | 365,947 -8,300 | -2% | -$695K |
|
3
Boston Scientific
BSX
$156B
| $28.4M | 7.69% | 1,731,900 -32,100 | -2% | -$527K |
|
|
BXLT
4
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $28.1M | 7.61% | +892,200 | New | +$28.1M |
|
5
Baxter International
BAX
$12.7B
| $27.6M | 7.47% | 839,400 +125,900 | +18% | +$4.14M |
|
|
6
Bristol-Myers Squibb
BMY
$96B
| $26.6M | 7.19% | 448,800 +169,400 | +61% | +$10M |
|
|
7
Ironwood Pharmaceuticals
IRWD
$214M
| $19M | 5.15% | 1,826,191 +423,300 | +30% | +$4.41M |
|
8
Revvity
RVTY
$10.5B
| $17.9M | 4.86% | 390,360 +35,300 | +10% | +$1.62M |
|
9
Cardinal Health
CAH
$35.5B
| $17.5M | 4.74% | 227,900 +18,500 | +9% | +$1.42M |
|
10
Bio-Rad Laboratories Class A
BIO
$8.06B
| $15.5M | 4.19% | 115,100 +9,700 | +9% | +$1.3M |
|
11
Integra LifeSciences
IART
$1.18B
| $13M | 3.52% | 218,463 +29,400 | +16% | +$1.75M |
|
12
Cigna
CI
$80.3B
| $11.7M | 3.17% | 86,600 +13,600 | +19% | +$1.84M |
|
13
Masimo
MASI
$7.59B
| $11.5M | 3.11% | 298,023 +25,400 | +9% | +$979K |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $11.2M | 3.02% | 107,063 +33,600 | +46% | +$3.5M |
|
15
Tenet Healthcare
THC
$16.3B
| $10.6M | 2.86% | 286,400 -6,600 | -2% | -$244K |
|
16
Owens & Minor
OMI
$378M
| $10.2M | 2.77% | 320,752 +86,500 | +37% | +$2.76M |
|
|
17
Stryker
SYK
$150B
| $9.14M | 2.47% | 97,083 -164,400 | -63% | -$15.5M |
|
|
18
Biogen
BIIB
$19.4B
| $8.35M | 2.26% | +28,600 | New | +$8.35M |
|
|
RAD
19
DELISTED
Rite Aid Corporation
RAD
| $7.77M | 2.1% | 1,280,500 +217,700 | +20% | +$1.32M |
|
20
Community Health Systems
CYH
$387M
| $7.55M | 2.04% | 176,600 +16,700 | +10% | +$714K |
|
|
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
| $7.46M | 2.02% | 86,545 -11,900 | -12% | -$1.03M |
|
|
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.76M | 1.56% | 350,920 +210,480 | +150% | +$3.45M |
|
|
MDCO
23
DELISTED
Medicines Co
MDCO
| $4.28M | 1.16% | 112,755 -337,995 | -75% | -$12.8M |
|
|
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $447K | 0.12% | 74,700 +5,200 | +7% | +$31.1K |
|
|
25
Teva Pharmaceuticals
TEVA
$21.1B
| – | – | -262,000 | Closed | -$15.5M |
|